ABIONYX Pharma
ENXTPA:ABNX
3,47
€-0,23 (-6,22%)
3,47
€-0,23 (-6,22%)
End-of-day quote: 04/07/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

€-0,13
Earnings Per Share
€0,13
Revenue Per Share
18,55%
Gross Margin %
€0,13 B
Market Cap
€0,00 B
Long-Term Debt
Earnings Per Share
€-0,13
Revenue Per Share
€0,13
Gross Margin %
18,55%
Market Cap
€0,13 B
Long-Term Debt
€0,00 B

Financials

Year Year 2026 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share €-0,13 €-0,12 €-0,22 €-0,23 €-0,08 €0,09 €-0,34 €-0,27 €-1,39 €-1,00
Earnings Earnings €-4,51M €-3,87M €-6,18M €-6,37M €-1,95M €1,95M €-6,41M €-4,92M €-25,35M €-17,78M
RPS Revenue Per Share €0,00 €0,13 €0,14 €0,19 €0,03 €0,00 €0,00 €0,01 €0,00 €0,00 €0,00
Revenue Revenue €0,00M €4,60M €4,60M €5,30M €0,70M €0,00M €0,00M €0,20M €0,00M €0,00M €0,00M
OCF Operating Cash Flow €0,00M €-3,61M €-4,24M €-6,50M €-6,70M €0,00M €-3,95M €-6,00M €-9,00M €-19,20M €0,00M
FCF Free Cash Flow €0,00M €-3,67M €-5,80M €-6,30M €-6,86M €0,00M €-3,95M €-6,01M €-9,31M €-19,19M €0,00M
OM Operating Margin 0,00% -98,11% -73,53% -78,24% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 18,55% 13,32% 12,11% 38,37% 0,00% 0,00% 100,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share €0,00 €-0,11 €-0,13 €-0,13 €-0,28 €-0,03 €-0,19 €-0,32 €-0,51 €-1,07 €-0,83
LT Debt Long-Term Debt N/A €0,61M €1,10M €1,42M €1,65M N/A N/A €0,50M €5,82M €6,76M €6,09M
Sha. Stocks 34,68M 34,68M 32,21M 28,1M 27,7M 24,4M 21,63M 18,86M 18,24M 18,24M 17,78M
×